UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology
Bioinformatics researchers at the University of California, San Diego and Genentech have developed a new, quicker way to sequence monoclonal antibodies – a process that is many times faster than the sequencing technology ...